Publicaciones en colaboración con investigadores/as de Boston University (22)

2022

  1. Mild-to-Moderate Kidney Dysfunction and Cardiovascular Disease: Observational and Mendelian Randomization Analyses

    Circulation, Vol. 146, Núm. 20, pp. 1507-1517

2021

  1. Correction to: Current evidence on the impact of medication optimization or pharmacological interventions on frailty or aspects of frailty: a systematic review of randomized controlled trials (European Journal of Clinical Pharmacology, (2021), 77, 1, (1-12), 10.1007/s00228-020-02951-8)

    European Journal of Clinical Pharmacology

  2. Current evidence on the impact of medication optimization or pharmacological interventions on frailty or aspects of frailty: a systematic review of randomized controlled trials

    European Journal of Clinical Pharmacology, Vol. 77, Núm. 1

2020

  1. Lipidomic profiling identifies signatures of metabolic risk

    EBioMedicine, Vol. 51

2019

  1. -AV-1451 binding profile in chronic traumatic encephalopathy: A postmortem case series

    Acta Neuropathologica Communications, Vol. 7, Núm. 1

  2. Equalization of four cardiovascular risk algorithms after systematic recalibration: Individual-participant meta-analysis of 86 prospective studies

    European Heart Journal, Vol. 40, Núm. 7, pp. 621-631

  3. International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders

    The Lancet Oncology, Vol. 20, Núm. 6, pp. e302-e312

2018

  1. Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

    The Lancet, Vol. 392, Núm. 10157, pp. 1519-1529

  2. Gene-level association analysis of systemic sclerosis: A comparison of African-Americans and White populations

    PLoS ONE, Vol. 13, Núm. 1

2014

  1. DIABETES-SPECIFIC NUTRITION ALGORITHM: A TRANSCULTURAL PROGRAM TO OPTIMIZE DIABETES AND PREDIABETES CARE

    CLINICAL NUTRITION: THE INTERFACE BETWEEN METABOLISM, DIET, AND DISEASE (CRC PRESS-TAYLOR & FRANCIS GROUP), pp. 209-239

  2. Derivation and validation of a set of 10-year cardiovascular risk predictive functions in Spain: The FRESCO Study

    Preventive Medicine, Vol. 61, pp. 66-74

  3. Exposure to ACE inhibitors prior to the onset of scleroderma renal crisis-results from the international scleroderma renal crisis survey

    Seminars in Arthritis and Rheumatism, Vol. 43, Núm. 5, pp. 666-672

  4. Glycated hemoglobin measurement and prediction of cardiovascular disease

    JAMA - Journal of the American Medical Association, Vol. 311, Núm. 12, pp. 1225-1233

  5. Immunochip analysis identifies multiple susceptibility loci for systemic sclerosis

    American Journal of Human Genetics, Vol. 94, Núm. 1, pp. 47-61

2013

  1. Lack of interaction of beta-cell-function-associated variants with hypertension on change in fasting glucose and diabetes risk: The Framingham Offspring Study

    Journal of Hypertension, Vol. 31, Núm. 5, pp. 1001-1009

2012

  1. Lipid-related markers and cardiovascular disease prediction

    JAMA - Journal of the American Medical Association, Vol. 307, Núm. 23, pp. 2499-2506

2011

  1. Clinical end points and response criteria in mycosis fungoides and Sézary syndrome: A consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer

    Journal of Clinical Oncology, Vol. 29, Núm. 18, pp. 2598-2607

  2. Genetic risk reclassification for type 2 diabetes by age below or above 50 years using 40 type 2 diabetes risk single nucleotide polymorphisms

    Diabetes Care, Vol. 34, Núm. 1, pp. 121-125

  3. Variants at the endocannabinoid receptor CB1 gene (CNR1) and insulin sensitivity, type 2 diabetes, and coronary heart disease

    Obesity, Vol. 19, Núm. 10, pp. 2031-2037

2009

  1. Major lipids, apolipoproteins, and risk of vascular disease

    JAMA, Vol. 302, Núm. 18, pp. 1993-2000